| Authors: |
Coffey GP; Biology and Pharmacology, Portola Pharmaceuticals, Inc., South San Francisco, California. gcoffey@portola.com., Feng J; Research and Development, Portola Pharmaceuticals, Inc., South San Francisco, California., Betz A; Research and Development, Portola Pharmaceuticals, Inc., South San Francisco, California., Pandey A; Medicinal Chemistry and Chemical Development, Portola Pharmaceuticals, Inc., South San Francisco, California., Birrell M; Corporate Development, Portola Pharmaceuticals, Inc., South San Francisco, California., Leeds JM; Drug Metabolism and Pharmacokinetics, Portola Pharmaceuticals, Inc., South San Francisco, California., Der K; Pharmacokinetics, Portola Pharmaceuticals, Inc., South San Francisco, California., Kadri S; Department of Pathology, University of Chicago, Chicago, Illinois., Lu P; Department of Pathology, University of Chicago, Chicago, Illinois., Segal J; Department of Pathology, University of Chicago, Chicago, Illinois., Wang YL; Department of Pathology, University of Chicago, Chicago, Illinois., Michelson G; Clinical Development, Portola Pharmaceuticals, Inc., South San Francisco, California., Curnutte JT; Research and Development, Portola Pharmaceuticals, Inc., South San Francisco, California., Conley PB; Biology, Portola Pharmaceuticals, Inc., South San Francisco, California. |
